Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Prospective Clinical Trial to Assess Procalcitonin-guidance and Molecular-guided Diagnosis as Mainstay for Therapy of Severe Infections (the MODIFY Trial)

NCT05909683 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.

NCT NCT05909683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05909683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Prospective Clinical Trial to Assess Procalcitonin-guidance and Molecular-guided Diagnosis as Mainstay for Therapy of Severe Infections (the MODIFY Trial)
Lead sponsor
Hellenic Institute for the Study of Sepsis
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 19, 2023
Completion date
April 15, 2026
Enrollment
190 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis